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Risk stratification in asymptomatic moderate to
severe aortic stenosis: the importance of the valvular,
arterial and ventricular interplay
Patrizio Lancellotti,1 Erwan Donal,2 Julien Magne,1 Marie Moonen,1 Kim O’Connor,1
Jean-Claude Daubert,2 Luc A Pierard1
ABSTRACT
Objective We sought to evaluate prognostic markers of
clinical outcome in asymptomatic patients with
moderate to severe aortic stenosis (AS).
Design Prospective follow-up of asymptomatic patients
with moderate to severe AS. The patients underwent
clinical and Doppler echocardiographic evaluation.
Setting Department of Cardiology.
Patients 163 patients with moderate to severe AS
(aortic valve area #0.6 cm2/m2).
Main outcome measures Risk stratification.
Predefined endpoints for assessing the outcome were
the occurrence during follow-up of symptoms, aortic
valve replacement or death.
Results During follow-up (mean, 20 (19) months), 11
patients developed symptoms but were not operated on,
57 required aortic valve replacement and six patients
died. In multivariable Cox regression analysis, four
parameters that were associated with the outcome were
identified: peak aortic jet velocity, left ventricular systolic
(LV) longitudinal deformation, valvulo-arterial impedance
and indexed left atrial area. Using receiver!operator
characteristic curve analysis, a peak aortic jet velocity
$4.4 m/s, a LV longitudinal myocardial deformation
#15.9%, a valvular-arterial impedance $4.9 mm Hg/ml
per m2 and an indexed left atrial area $12.2 cm2/m2
were identified as the best cut-off values to be
associated with events.
Conclusions In asymptomatic patients with moderate
to severe AS, measurements that integrate the
ventricular, vascular and valvular components of the
disease improve risk stratification.
Aortic stenosis (AS) is the most common valvular
disease in developed countries. Its prevalence is
expected to markedly increase as the population
ages. Patients with symptoms with severe AS have
a high mortality rate and require prompt aortic
valve replacement (AVR).1 Although asymptomatic
patients are at increased risk for untoward events,
their management remains controversial.2 3 Current
guidelines consider surgery as reasonable in asymp-
tomatic patients with reduced (<50%) left ventric-
ular (LV) ejection fraction and in patients who
exhibit symptoms during an exercise test.4 5 Im-
proving the identiﬁcation of patients at high risk of
cardiac events is a challenging issue.
We hypothetised that measurements integrating
valvular, vascular and ventricular components of
the disease could identify new markers of guarded
prognosis and allow a better timing of intervention.
To test this hypothesis, we prospectively studied
consecutive patients with asymptomatic moderate
to severe AS who did not fulﬁl current criteria of
reasonable surgical option at the time of inclusion.
METHODS
Patient population
A total of 163 asymptomatic patients with signiﬁ-
cant AS were enrolled between January 2000 and
December 2007 in this prospective study. All
patients met the following speciﬁc criteria:
moderate to severe AS deﬁned by an aortic valve
area #0.6 cm2/m2, absence of symptoms according
to a careful history taking by both the referring
physician and us, normal LV ejection fraction
($55%) as calculated by two-dimensional echo-
cardiography, no more than mild associated cardiac
valve lesion and sinus rhythm. At study entry, the
following clinical data were collected: age, gender,
history of hypercholesterolemia (total cholesterol
>190 mg/dl or patients under lipid lowering
therapy), current smoking, diabetes mellitus,
systemic arterial hypertension (blood pressure $
140/90 mm Hg or patients under anti-hypertensive
treatment) and overweight (body mass index
>25 kg/m2). The protocol was approved by the
relevant institutional review boards and all patients
gave written informed consent.
Echocardiographic measurements
Doppler echocardiographic examinations were
performed with the use of a VIVID 7 ultrasound
system (General Electric Healthcare, Little Chal-
font, UK). M-mode, two-dimensional, colour
Doppler and pulsed-wave and continuous-wave
Doppler data were stored on a dedicated worksta-
tion for off-line analysis. For each measurement, at
least two cardiac cycles were averaged. Continuous
wave Doppler was used to measure the aortic
transvalvular maximal velocities; peak and mean
gradients were calculated using the simpliﬁed
Bernoulli equation. Aortic valve area was calculated
using the continuity equation.6 Stroke volume was
calculated using the Doppler method as follows:
0.785 3 (LV outﬂow tract diameter)2 3 LV outﬂow
tract velocity time integral. LV end-diastolic and
end-systolic volumes and ejection fraction were
measured by the bi-apical Simpson disk method.7
Left atrial area was obtained by planimetry of an
end-systolic frame from the apical four-chamber
view.8 Peak E-wave and A-wave velocities of the
mitral inﬂow were measured using pulsed wave
Doppler. To complete the analysis of the LV systolic
function, the global longitudinal myocardial
1Department of Cardiology,
University Hospital Sart Tilman,
Lie`ge, Belgium
2CHU de Ponchaillou, Rennes,
France
Correspondence to
P Lancellotti, Department of
Cardiology, University Hospital,
Domaine Universitaire du Sart
Tilman - B.35 - 4000 Lie`ge,
Belgium;
plancellotti@chu.ulg.ac.be
Accepted 24 February 2010
Lancellotti P, Donal E, Magne J, et al. Heart (2010). doi:10.1136/hrt.2009.190942 1 of 8
Original article
 Heart Online First, published on May 18, 2010 as 10.1136/hrt.2009.190942
Copyright Article author (or their employer) 2010. Produced by BMJ Publishing Group Ltd (& BCS) under licence. 
 group.bmj.com on July 12, 2010 - Published by heart.bmj.comDownloaded from 
deformation was evaluated from standard two-dimensional
images (frame rates $60/s). Two-dimensional strain is a non-
Doppler-based method. In brief, by tracing the endocardial
borders on an end-systolic frame, the software automatically
tracked the contour on the subsequent frames. Adequate
tracking was veriﬁed in real-time and was manually corrected, if
necessary. The global longitudinal deformationdstraindwas
the average of the segment strains from the apical four-chamber
and two-chamber views.9 The peak velocities of the E wave
(early diastole) and the Awave (late diastole) were measured and
the ratio of these velocities was calculated.
Systemic arterial haemodynamics and global LV afterload
Systemic arterial pressure was measured with the use of an
arm-cuff sphygmomanometer at the time of the Doppler
echocardiographic examination. The ratio of the stroke volume
index to the brachial pulse pressure (the difference between the
systolic and the diastolic blood pressure) was used as an indirect
measure of the total systemic arterial compliance. To estimate
the global LV afterload, we calculated the valvulo-arterial
impedance as the sum of the systolic arterial pressure and the
mean transvalvular pressure gradient divided by the stroke
volume index.10
Exercise testing
Symptom-limited graded bicycle exercise tests were performed
at inclusion in all patients. After an initial workload of 25 W
maintained for 2 min, the load was increased by steps of 25 W
every 2 min. A 12-lead ECG was monitored continuously. The
exercise test was interrupted when age-related maximum heart
rate was reached or, in case of symptoms (angina, dyspnea), fall
in blood pressure or ventricular arrhythmias. The test was
considered abnormal if the patient presented $1 of the
following criteria: angina, evidence of dyspnea, dizziness,
syncope or near-syncope, $2 mm ST segment depression in
comparison to baseline levels, rise in systolic blood during
exercise <20 mm Hg or a fall in blood pressure and complex
ventricular arrhythmias.
Follow-up
Follow-up information was obtained from interviews with the
patients, their relatives or their physicians every six to
12 months, according to guidelines.4 5 Particular care was taken
to obtain information regarding the development of symptoms,
the eventual AVR and death. The clinical management of the
patients was determined independently by their personal
physicians.
Statistical analysis
Data are expressed as mean6SD or percentages unless otherwise
speciﬁed. Group comparisons were obtained for categorical
variables with c2 test and for continuous variables with
one-way analysis of variance. The combined end-point of the
study included: the development of signiﬁcant symptoms
(angina, dyspnea, syncope, heart failure), cardiac death and the
clinical need of AVR. The analysis was performed by censoring
follow-up at the time of cardiac surgery if eventually performed.
Multivariate Cox proportional-hazards regression procedure was
used to identify independent predictors of events (Statistica
Software, V.7). Clinically relevant variables with a p value <0.1
on univariable analysis were incorporated into the multivariable
models. Variables were used in the model as continuous or
categorical variables when possible. The KaplaneMeier method
was used for cumulative survival analysis with the log-rank test
for assessing statistical differences between curves. A p value
<0.05 was considered to indicate statistical signiﬁcance. Recei-
vereoperator characteristic curves were generated to determine
the performance of independent variables for the prediction of
cardiac events. An additional analysis was performed using
multiple logistic regression to identify the independent predictor
of 1-year event-free survival. Patients with less than 1-year
follow-up were excluded from this analysis.
RESULTS
Characteristics of the patients
Based on the patient’s history and the echocardiographic
analysis, the origin of AS was calciﬁc in 148 patients (91%) and
bicuspid in 15 (9%). The aortic valve area ranged from 0.2 to
0.6 cm2/m2 and the mean transaortic pressure gradient ranged
from 25 to 86 mm Hg. Mean LV ejection fraction was 67 (7)%
(55e84%). A history of systemic arterial hypertension was
noted in 81 patients; 72 patients had hypercholesterolemia and
27 patients were diabetic. At inclusion, the exercise test was
abnormal (dyspnea, n¼25; angina¼3; both symptoms, n¼2; fall
or rise in systolic blood during exercise <20 mm Hg, n¼15;
$2 mm ST segment depression as compared with rest, n¼13;
combined parameters, n¼11) in 69 (42%) patients.
Clinical outcome
Follow-up information was available in all 163 patients. The
mean follow-up time was 20619 months (range 4e102 months)
(ﬁgure 1). During follow-up, predeﬁned end-points were reached
in 74 patients including six deaths, 57 patients who required
AVR and 11 patients who developed symptoms but did not have
valve replacement (three refused surgery and eight were on the
waiting list at the time of follow-up). Six patients presented
a death due to cardiac causes (three to congestive heart failure
related to AS and three sudden deaths without preceding
symptoms). One additional patient died postoperatively from
endocarditis. Another patient died from cancer. AVR was
required by the development of symptoms in 44 patients within
15 (13) months following inclusion. The predominant symp-
toms were severe dyspnea, angina, or syncope in 26, six and
three patients respectively. Nine patients developed both angina
and dyspnea. In the remaining 13 patients, surgery was
performed because of the onset of severely symptomatic atrial
Figure 1 KaplaneMeier event-free survival curve of the whole cohort
(n¼163). The mean6SD survival rates at 2 and 4 years are indicated.
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ﬁbrillation (n¼1), a newly positive exercise test during follow-up
(n¼6) or equivocal symptoms (n¼6). Eighty-nine patients
remained free of clinical event after a follow-up of 26622
months.
Predictors of events
The clinical and echocardiographic characteristics of the patients
who remained asymptomatic and those who experienced an
event are listed in table 1. No clinical parameters (age, sex, risk
factors, blood pressure) allowed signiﬁcant distinction between
the two groups. By contrast, patients who developed events had
markedly reduced aortic valve area and systemic arterial
compliance and had signiﬁcantly higher valvulo-arterial
impedance and larger left atrium than those remaining asymp-
tomatic. Although conventional indices of global LV systolic
function (LV volumes and ejection fraction) were statistically
similar in the two groups, the LV longitudinal myocardial
deformation was impaired in the group of patients who
developed an event. The response to exercise was more often
abnormal in these patients. With multivariable Cox regression
analysis, four parameters emerged as independently associated
with the combined end-point: peak aortic jet velocity (p¼0.04),
LV longitudinal myocardial deformation (p¼0.03), valvulo-arte-
rial impedance (p¼0.001) and indexed left atrial area (p¼0.007)
(table 2). Using receivereoperator characteristic curve analysis
(ﬁgure 2), a peak aortic jet velocity $4.4 m/s, a LV longitudinal
myocardial deformation #15.9%, a valvular-arterial impedance
$4.9 mm Hg/ml per m2 and an indexed left atrial area
$12.2 cm2/m2 were identiﬁed as the best cut-off values to be
associated with events (ﬁgure 3). When these were entered as
categorical parameters in the same multivariable model as in
table 2, all remained signiﬁcant.
In the population, 57 patients (34%) cumulated two risk
markers and 30 (18%) had three or four predictive markers. The
RR of events rose with the increased number of risk markers
(ﬁgure 4). At 2 years, the probability of remaining free of cardiac
events was 7666% in the patients with no risk marker, 73610%
in the patients with one risk variable, 4068% in the patients
with two risk markers and 1568% in the patients with three or
four risk markers (p<0.001).
During the ﬁrst year following inclusion, 49 patients had an
event (32% of the patients with follow-up >1 year). In multi-
variable logistic regression, valvulo-arterial impedance, LV
longitudinal strain and indexed left atrial surface came out as
independent determinants of 1-year event-free survival (table 3).
To note in the six patients who died, the valvulo-arterial
impedance was 5.860.9 mm Hg/ml per m2 and the aortic valve
area 0.3960.02 cm2/m2. Death occurred at a mean follow-up of
1065 months.
On the other hands, in patients with a negative exercise test,
peak aortic jet velocity (p¼0.03), LV longitudinal myocardial
deformation (p¼0.012), valvulo-arterial impedance (p¼0.035)
and indexed left atrial area (p¼0.003) remained associated in the
multivariable model with the outcomes.
Table 1 Demographic, clinical and echocardiographic characteristics*
Variables All patients (n[163) No event, (n[89, 55%) Events, (n[74, 45%) p Value
Clinical variables
Agedyears 70610 69610 70610 0.79
Male genderdno (%) 106 (65) 63 (71) 43 (58) 0.10
Overweightdno (%) 48 (29) 26 (29) 22 (30) 0.54
Hypertensiondno (%) 81 (50) 41 (46) 40 (54) 0.26
Diabetes mellitusdno (%) 27 (17) 15 (17) 12 (16) 0.50
Hypercholesterolemiadno (%) 72 (44) 41 (46) 31 (42) 0.28
Current smokingdno (%) 45 (28) 24 (27) 21 (28) 0.98
Serum creatininedmg/l 8.761.9 8.661.9 8.862.0 0.35
Systemic arterial haemodynamics
Systolic arterial pressuredmm Hg 142618 143618 140619 0.33
Diastolic arterial pressuredmm Hg 76611 77610 75611 0.18
Systemic arterial compliancedml/mm Hg/m2 0.760.3 0.860.32 0.6660.27 0.003
Aortic stenosis severity
Indexed aortic valve areadcm2/m2 0.4560.09 0.4760.08 0.4360.09 0.01
Peak aortic velocitydm/s 4.260.6 4.1360.6 4.3660.6 0.0019
Mean pressure gradientdmm Hg 46614 45615 47613 0.25
LV global afterload
Valvulo-arterial impedancedmm Hg ml/m2 4.461.3 3.9760.93 5.0261.44 <0.00001
LV massdg/m2 91645 96650 84637 0.17
LV function
LV end-diastolic diameterdmm 42612 41611 44610 0.22
LV end-diastolic volumedml 1006133 99633 100633 0.85
LV end-systolic volumedml 35619 35617 36620 0.61
LV ejection fractiond% 6669 6668 6669 0.97
Midwall fractional shorteningd% 21610 2166 20613 0.11
LV longitudinal straind% 15.763.1 16.662.7 14.763.1 <0.0001
LA area indexdcm2/m2 12.463.5 10.762.4 14.563.5 <0.00001
Mitral E wavedm/s 0.8360.27 0.8160.23 0.8660.33 0.25
Mitral A wavedm/s 0.9160.29 0.9260.29 0.8960.3 0.65
Mitral E/A ratio 0.9960.54 0.9460.36 1.0560.69 0.19
Abnormal response to exercise 69 (42) 26 (29) 43 (58) 0.0002
LV, left ventricular; LA, left atrial.
*Values are means6SD.
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Reproducibility of measurements
The reproducibility of measurements was tested by random
selection of 15 patients enrolled in Rennes. There were good
interobserver agreements for LV volumes (r¼0.87), LV ejection
fraction (r¼0.85), aortic pressure gradients (r¼0.91), stroke
volume (r¼0.92) and aortic valve area (r¼0.88). Low coefﬁcients
of variation were found between observers with mean relative
differences of 6.1% for all the parameters (range 4.6e12.4%). All
measurements concerning myocardial deformation were
performed in Liège. The inter- (r¼0.89) and intraobserver
(r¼0.86) regression coefﬁcients for LV longitudinal myocardial
deformation have been reported as good by our group.9
DISCUSSION
In this prospective study of 163 patients with asymptomatic
moderate to severe AS, we identiﬁed four Doppler-echocardio-
graphic parameters that were strongly associated with the
occurrence of cardiac events: aortic jet velocity, a measure of
stenosis severity; valvulo-arterial impedance, an estimate of
global LVafterload; left atrial area index, a marker of LV diastolic
dysfunction; and LV longitudinal deformation, an indicator of
subclinical LV systolic dysfunction. In contrast, no clinical
variables were independently associated with outcome. At
2 years, only 43% of patients had an uneventful clinical course.
The likelihood of remaining free of cardiac events decreased
substantially according to the number of risk markers. These
data emphasise that the prognosis of patients with asymp-
tomatic AS depends not only on stenosis severity but also on the
level of LV load and its consequences on LV function.
Table 2 Univariable and multivariable analysis of event-free survival
Variables
Univariable Multivariable
HR (95% CI) p HR (95% CI) p
Demographic and clinical data
Age 1.01 (0.98 to 1.03) 0.62 e e
Female gender 1.6 (0.97 to 2.5) 0.07 1.4 (0.8 to 2.3) 0.23
Overweight 0.8 (0.5 to 1.3) 0.43 e e
Hypertension 1.3 (0.8 to 2.1) 0.24 e e
Diabetes mellitus 1.2 (0.6 to 2.2) 0.57 e e
Hypercholesterolemia 1.2 (0.7 to 1.9) 0.45 e e
Current smoking 1.04 (0.6 to 1.7) 0.89 e e
Serum creatinine 1.1 (0.9 to 1.3) 0.23 e e
Systemic arterial haemodynamics
Systolic arterial pressure 1.01 (0.9 to 1.1) 0.12 e e
Diastolic arterial pressure 1.01 (0.9 to 1.1) 0.19 e e
Systemic arterial compliance 4 (1.25 to 10) 0.016 2.3 (0.6 to 9.1) 0.24
Aortic stenosis severity
Indexed aortic valve area 1.4 (1.1 to 1.8) 0.01 e e
Peak aortic velocity 1.9 (1.2 to 2.8) 0.003 1.6 (1.01 to 2.5) 0.04
Mean pressure gradient 1.01 (0.9 to 1.03) 0.06 e e
LV global afterload
Valvulo-arterial impedance 1.6 (1.3 to 1.8) <0.0001 1.6 (1.25 to 2.0) 0.001
LV mass 1 (0.9 to 1.1) 0.87 e e
LV function
LV end-diastolic diameter 0.98 (0.87 to 1.2) 0.43 e e
LV end-diastolic volume 1 (0.9 to 1) 0.81 e e
LV end-systolic volume 1 (0.9 to 1) 0.29 e e
LV ejection fraction 1.01 (0.9 to 1.02) 0.34 e e
Midwall fractional shortening 0.98 (0.93 to 1.03) 0.23 e e
LV longitudinal strain 1.1 (1.05 to 1.2) <0.0001 1.1 (1.01 to 1.2) 0.03
LA area index 1.1 (1.05 to 1.12) <0.0001 1.1 (1.04 to 1.2) 0.007
Mitral E wave 2.6 (1 to 6.2) 0.034 1.3 (0.4 to 4) 0.84
Mitral A wave 1.1 (0.4 to 2) 0.81 e e
Mitral E/A ratio 1.6 (1.1 to 2.4) 0.04 1.3 (0.7 to 2.3) 0.43
Abnormal response to exercise 2.05 (1.3 to 3.4) 0.002 1.1 (0.6 to 2) 0.76
LV, left ventricular; LA, left atrial.
Figure 2 Receiver!operator characteristic curves analysis for the
prediction of events. Cut-off values were indicated using a square for
indexed left atrial area (12.2 cm2/m2, area under the curve [AUC]¼0.62),
a triangle for longitudinal strain (15.9%, AUC¼0.70), a circle for valvulo-
arterial impedance (4.9 mm Hg/ml/m2, AUC¼0.74) and a lozenge for
peak aortic velocity (4.4 m/s, AUC¼0.83).
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The management of asymptomatic patients with severe AS is
controversial. The immediate risks of AVR are weighed against
the later risk of events without surgical intervention. Physicians
may feel uncomfortable about delaying surgery until symptoms
occur. Indeed, many patients do not report their symptoms
promptly, some patients deny symptoms and the risk of death is
signiﬁcant if the patients need to wait several months for
surgery.11
Previous studies have shown that the outcome of patients
with asymptomatic AS could be dependent on several clinical,
biological and echocardiographic variables: age, functional
status, chronic renal failure, C-Reactive protein level, severity of
stenosis and its rate of progression and the extent of valve
calciﬁcation.12e14 The occurrence of symptoms during an exer-
cise test can identify patients who will develop symptoms
during following year, but elderly and/or inactive patients are
not always able to exercise.15 16 In the present study, although
an abnormal response to exercise was associated with the
outcome in univariable analysis, it did not emerge as an inde-
pendent predictor in the multivariable model. This could be
related to the subjectivity of symptoms during the test and its
low predictive value in elderly subjects.15
In this study, age, mean pressure gradient, LV mass, LV
volumes and ejection fraction were similar in patients who
developed an event and in those who remained asymptomatic
over the study period. Mean age of our patients was 70 years and
the majority of them had moderate or severe valve calciﬁcation.
Our results conﬁrm that the severity of AS is a strong predictor
of outcome. Although mean pressure gradient was similar in the
two groups, indexed valve area was signiﬁcantly lower in
patients who had cardiac events. Aortic jet velocity was selected
on multivariable analysis as a stronger predictor of prognosis and
particularly of mid-term outcome. Jet velocity is recorded
directly on Doppler examination, is reproducible, and does not
require calculations.13 These data are in line with recent publi-
cations.17 Rosenhek et al have showed that patients with very
severe AS have a poor prognosis with a high event rate and a risk
of rapid functional deterioration. In our study, 15 of 20 patients
Figure 3 KaplaneMeier event-free survival curves according to categorical variables that were selected in the Cox proportional-hazards regression
analysis. Peak aortic velocity (A), valvulo-arterial impedance (B), longitudinal strain (C), indexed left atrial area (D). The mean6SD survival rates at two
and 4 years are indicated. Ao denotes aortic, V-Ai valvulo-arterial impedance, Long. longitudinal and LA left atrial.
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with an aortic jet velocity >5 m/s developed cardiac events
during follow-up (15/20 vs 59/84, p¼0.004).
AS cannot be viewed as an isolated disease of the valve.18 The
prevalence of atherosclerosis and hypertension is high in these
patients. Both conditions can accelerate arterial stiffness.19 The
increase in LV afterload does not only result from outﬂow
obstruction but also from reduced systemic arterial compliance.
A recent approach to assess global afterload incorporates the
degree of valve stenosis and the systemic arterial compliance by
calculating valvulo-arterial impedance.10 Mean pressure gradient
and stroke volume index are obtained by Doppler echocardiog-
raphy. Systolic arterial pressure is included in the numerator of
the formula and should thus be recorded systematically at the
time of echocardiographic examination. In retrospective studies,
a valvulo-arterial impedance >5 mm Hg/ml/m2 has been found
to be independently associated with a 4-fold increase in risk of
LV dysfunction and a value of >5.5 mm Hg/ml/m2 was associ-
ated with a 2.5-fold increase in risk of mortality in patients with
symptomatic or asymptomatic AS.20 Our prospective study
conﬁrms that patients with increased valvulo-arterial impedance
had a higher risk of developing events. Increased global afterload
was notably associated with early cardiac events during the ﬁrst
year of follow-up.
Prolonged high LV global afterload can exceed the limit of LV
compensatory mechanisms and lead to an intrinsic impairment
of myocardial function. When cellular adaptation is exhausted,
LV ﬁlling pressure increases, producing increased left atrial wall
tension and myocyte stretch inducing myolysis, ﬁbrosis,
apoptosis and, in turn, atrial enlargement.21 Left atrial size
increases with worsening diastolic dysfunction and reﬂects the
magnitude and the chronicity of the increased LV ﬁlling pres-
sure.22 In the present study, left atrial area index was found to be
a powerful prognostic marker. About one-half (46%) of our
patients had a signiﬁcant enlargement of the left atrium. In this
subgroup of patients, the 2-year probability of events was 77%.
After surgery, Rossi et al showed that left atrial size can predict
postoperative symptomatic improvement.23
Figure 4 KaplaneMeier event-free survival curves according to the
cumulative number of risk markers (indexed left atrial area, valvulo-
arterial impedance, maximum aortic jet velocity, longitudinal strain). The
mean6SD survival rates at 2 and 4 years are indicated.
Table 3 Univariable and multivariable analysis of 1-year event-free survival
Variables
Univariable Multivariable
OR (95% CI) p OR (95% CI) p
Demographic and clinical data
Age 1.01 (0.97 to 1.04) 0.81 e e
Female gender 1.7 (0.85 to 3.5) 0.13 e e
Overweight 0.6 (0.3 to 1.3) 0.19 e e
Hypertension 0.9 (0.5 to 1.8) 0.81 e e
Diabetes mellitus 1.2 (0.5 to 2.9) 0.73 e e
Hypercholesterolemia 1.5 (0.8 to 3.1) 0.24 e e
Current smoking 0.99 (0.5 to 2.1) 0.99 e e
Serum creatinine 1.1 (0.9 to 1.3) 0.25 e e
Systemic arterial haemodynamics
Systolic arterial pressure 0.99 (0.97 to 1.01) 0.19 e e
Diastolic arterial pressure 0.99 (0.96 to 1.02) 0.45 e e
Systemic arterial compliance 0.3 (0.1 to 1.5) 0.15 e e
Aortic stenosis severity
Indexed aortic valve area 1.7 (0.95 to 3.05) 0.07 e e
Peak aortic velocity 1.5 (1.02 to 2.3) 0.04 1.5 (0.8 to 2.9) 0.19
Mean pressure gradient 1.02 (0.99 to 1.05) 0.07 e e
LV global afterload
Valvulo-arterial impedance 1.7 (1.3 to 2.3) <0.0001 1.5 (1.1 to 2.04) 0.01
LV mass 1.01 (0.99 to 1.06) 0.83 e e
LV function
LV end-diastolic volume 1 (0.99 to 1.01) 0.94 e e
LV end-systolic volume 1.01 (0.98 to 1.02) 0.82 e e
LV ejection fraction 0.99 (0.95 to 103) 0.54 e e
LV longitudinal strain 1.2 (1.1 to 1.4) 0.001 1.2 (1.02 to 1.3) 0.01
LA area index 1.2 (1.1 to 1.3) 0.001 1.1 (1.02 to 1.3) 0.02
Mitral E wave 2.1 (0.6 to 7) 0.21 e e
Mitral A wave 0.7 (0.2 to 2.3) 0.56 e e
Mitral E/A ratio 1.5 (0.8 to 2.9) 0.19 e e
Abnormal response to exercise 1.9 (0.9 to 3.9) 0.08 1.14 (0.5 to 2.7) 0.75
LV, left ventricular; LA, left atrial.
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In the pressure overloaded myocardium, continuous turnover
of the extracellular matrix occurs during the progression from
compensatory hypertrophy to heart failure. A longstanding
increase in global LV afterload results in LV concentric
hypertrophy.24 For a similar extent of intrinsic myocardial
shortening, the LV ejection fraction tends to increase in relation
to the extent of LV concentric remodelling.24 Although contro-
versial, weight of opinion is considered in favour of surgery in
asymptomatic patients with severe AS who present with an
ejection fraction below 50%.4 5 However, LV ejection fraction
remains frequently normal.20 Indeed, the ejection fraction was
identical in the two groups of our population. Longitudinal
function is governed by the subendocardial myocardial ﬁbres
which are more likely to be affected by microvascular
ischemia.25 In hypertrophic myocardium, myocardial blood ﬂow
is maldistributed, and oxygen supply to the endocardium is
limited. In addition, subendocardial function of the left ventricle
may be depressed in patients whose conduct arteries are stiffer
and less compliant than normal.19 The LV longitudinal function
can be reliably quantitated by the measurement of myocardial
deformation from the speckle tracking analysis.16 25 In asymp-
tomatic patients with AS, impaired subendocardial function has
been shown to be associated with impaired exercise tolerance
and changes in symptomatic status during short-term follow-
up.25e28 Our results extend these preliminary data. Reduced
longitudinal contraction identiﬁed a subset of patients at higher
risk of developing cardiac events. Patients with LV longitudinal
strain #15.9% had an excess risk of death, symptoms or surgery
that was more than twice that of patients with preserved
longitudinal function.
Our results strengthen the need for a comprehensive eval-
uation of asymptomatic patients with AS that goes beyond
the standard measures of mean pressure gradient and aortic
valve area. They highlight the combined role of both outﬂow
obstruction and the peripheral circulation and their conse-
quences on LV systolic and diastolic function. Patients with no
or only one risk marker could be followed until symptoms
develop. Patients who combine two risk markers should be
carefully followed as 60% event rate at 2 years can be
expected. In the presence of three or four risk markers, early
AVR should be considered as such patients represent a very
high-risk group.
Study limitations
In the present study, we did not assess the presence and extent
of coronary atherosclerosis in patients who were not submitted
to surgery. To note, 39 patients underwent coronary
angiography during follow-up. Multivessel disease was observed
in 22, single-vessel lesions in four and non-signiﬁcant coronary
stenosis (<50%) in 13. As the present study was performed
before the European recommendations of 2007, the results of the
exercise test likely had no or minimal impact on patient
management. The decision to perform surgery was made by
individual cardiologists in charge of the patients. AVR could be
considered as a soft event. However, in the present study,
surgery was mainly dictated by the onset of symptoms, which
are currently a class I indication for intervention. Moreover,
serial echocardiographic examinations were available in a limited
number of patients. Therefore, the prognostic importance of the
rate of progression could not be evaluated. Finally, all measure-
ments made in the present study may lengthen analysis.
However, it should be highlighted that their analysis in the
setting of AS are currently recommended. The analysis of LV
myocardial deformation and the calculation the valvulo-arterial
impedance take > or <2 min. Finally, all these measurements are
exposed to source of errors and required learning curves.
CONCLUSIONS
In patients with asymptomatic moderate to severe AS,
measurements that integrate the ventricular, vascular and
valvular components of the disease improve risk stratiﬁcation
and may help to identify patients who could beneﬁt from an
early elective aortic valve surgery.
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